Literature DB >> 20234344

Familial aggregation of irritable bowel syndrome: a family case-control study.

Yuri A Saito1, Gloria M Petersen, Joseph J Larson, Elizabeth J Atkinson, Brooke L Fridley, Mariza de Andrade, G Richard Locke, Janice M Zimmerman, Ann E Almazar-Elder, Nicholas J Talley.   

Abstract

OBJECTIVES: Irritable bowel syndrome (IBS) clusters in families, but previous studies documented family history only from patients. We have shown that patient-relative agreement on IBS status is poor. Thus, we conducted a family case-control study with direct survey of symptoms from family members to better quantitate the aggregation of IBS in families. The aims of this study were to (i) compare the prevalence of IBS in case-relatives with control-relatives, and (ii) determine whether gender, relationship, predominant symptom, and environmental risk factors affect familial aggregation.
METHODS: Outpatients with IBS, matched controls, and their first-degree relatives completed a bowel symptom questionnaire. Percent of cases and controls with a family history were compared and odds ratios were computed using chi(2)-test; recurrence risks to relatives were computed using logistic regression and generalized estimating equations.
RESULTS: Data were collected from 477 cases, 297 controls, 1,492 case-relatives, and 936 control-relatives. Probands had a median age of 50 and 78% were women. 50% of case and 27% of control families had at least another relative with IBS yielding an odds ratio of 2.75 (95% CI: 2.01-3.76, P<0.0001). When aggregation estimates were reevaluated stratifying by relative relationship or proband gender, generational and gender effects were not observed. Familial clustering by bowel habit was weakest for diarrhea, and strongest for alternating bowel habits.
CONCLUSIONS: IBS aggregates strongly in families. The strength of the association does vary somewhat by relationship to proband, but the lack of association in spouses supports either a possible genetic etiology or a shared household environmental exposure as an underlying cause of IBS.

Entities:  

Mesh:

Year:  2010        PMID: 20234344      PMCID: PMC2875200          DOI: 10.1038/ajg.2010.116

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

1.  The Psychosomatic Symptom Checklist revisited: reliability and validity in a chronic pain population.

Authors:  J T Chibnall; R C Tait
Journal:  J Behav Med       Date:  1989-06

2.  A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group.

Authors:  S Bellentani; P Baldoni; S Petrella; C Tata; C Armocida; P Marchegiano; G Saccoccio; F Manenti
Journal:  Fam Pract       Date:  1990-12       Impact factor: 2.267

3.  Familial association in adults with functional gastrointestinal disorders.

Authors:  G R Locke; A R Zinsmeister; N J Talley; S L Fett; L J Melton
Journal:  Mayo Clin Proc       Date:  2000-09       Impact factor: 7.616

4.  Intergenerational transmission of gastrointestinal illness behavior.

Authors:  R L Levy; W E Whitehead; M R Von Korff; A D Feld
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

5.  Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology.

Authors:  R L Levy; K R Jones; W E Whitehead; S I Feld; N J Talley; L A Corey
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

6.  Epidemiology of irritable bowel syndrome in the United States.

Authors:  R S Sandler
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

Review 7.  Gender differences in irritable bowel syndrome.

Authors:  Heather J Chial; Michael Camilleri
Journal:  J Gend Specif Med       Date:  2002 May-Jun

8.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Familial aggregation of irritable bowel syndrome: a prospective study.

Authors:  J S Kalantar; G R Locke; A R Zinsmeister; C M Beighley; N J Talley
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

10.  Irritable bowel syndrome aggregates strongly in families: a family-based case-control study.

Authors:  Y A Saito; J M Zimmerman; W S Harmsen; M De Andrade; G R Locke; G M Petersen; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2008-07       Impact factor: 3.598

View more
  28 in total

1.  Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact.

Authors:  Richard N Fedorak; Stephen J Vanner; William G Paterson; Ron J Bridges
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

2.  Rare Variants of the Serotonin Transporter Are Associated With Psychiatric Comorbidity in Irritable Bowel Syndrome.

Authors:  Ruth Kohen; Julia H Tracy; Eric Haugen; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2016-02-24       Impact factor: 2.522

3.  Family history of mental illness or alcohol abuse and the irritable bowel syndrome.

Authors:  James R Knight; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  J Psychosom Res       Date:  2014-12-03       Impact factor: 3.006

4.  Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.

Authors:  Arthur Beyder; Amelia Mazzone; Peter R Strege; David J Tester; Yuri A Saito; Cheryl E Bernard; Felicity T Enders; Weronica E Ek; Peter T Schmidt; Aldona Dlugosz; Greger Lindberg; Pontus Karling; Bodil Ohlsson; Maria Gazouli; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Michael Camilleri; G Richard Locke; Nicholas J Talley; Mauro D'Amato; Michael J Ackerman; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2014-03-05       Impact factor: 22.682

Review 5.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

6.  Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study.

Authors:  Joseph Y Chang; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

7.  Comparison of Lactase Variant MCM6 -13910 C>T Testing and Self-report of Dairy Sensitivity in Patients With Irritable Bowel Syndrome.

Authors:  Ann E Almazar; Joseph Y Chang; Joseph J Larson; Elizabeth J Atkinson; G Richard Locke; Nicholas J Talley; Yuri A Saito
Journal:  J Clin Gastroenterol       Date:  2019-07       Impact factor: 3.062

Review 8.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

9.  Development and validation of new disease-specific measures of somatization and comorbidity in IBS.

Authors:  Elizabeth W MacLean; Olafur S Palsson; Marsha J Turner; William E Whitehead
Journal:  J Psychosom Res       Date:  2012-08-31       Impact factor: 3.006

10.  Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity.

Authors:  S H Park; E J Videlock; W Shih; A P Presson; E A Mayer; L Chang
Journal:  Neurogastroenterol Motil       Date:  2016-04-08       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.